Rare diseases
Investigational molecules
Locations
2000 Sierra Point Parkway Suite 501, 94005-1874, United States
Research activity centers on pediatric low-grade glioma, with attention to tumors carrying activating RAF and BRAF alterations. The clinical focus includes children and adolescents with newly diagnosed, relapsed, or progressive disease requiring systemic therapy.
These studies reflect a strong interest in targeted treatment options for pediatric central nervous system tumors.
Day One Biopharmaceuticals Inc. runs clinical trials in conditions such as Malignant glioma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Denmark
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
